v3.22.4
Reportable Segment and Major Customers Information - Additional Information (Detail)
3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Two life science segment customers and its affiliates [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Concentration risk percentage 10.00%  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | VIVO Life Science [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Concentration risk percentage 11.00%  
Customer Concentration Risk [Member] | Life Science Segment Ten Largest Customer [Member] | Sales Revenue, Net [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Concentration risk percentage 13.00% 42.00%
Customer Concentration Risk [Member] | Life Science Segment Ten Largest Customer [Member] | Sales Revenue, Net [Member] | Operating Segments [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Concentration risk percentage 42.00% 67.00%
Customer Concentration Risk [Member] | One Single Customer [Member] | Sales Revenue, Net [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Concentration risk percentage 10.00%  
Customer Concentration Risk [Member] | VIVO Customer A Member [Member] | Accounts Receivable [Member] | VIVO Diagnostics [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Concentration risk percentage 12.00%  
Product Concentration Risk [Member] | Three Diagnostics Product Families [Member] | Sales Revenue, Net [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Concentration risk percentage 57.00% 32.00%